Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prospective Bladder Cancer Infrastructure (ProBCI)
Sponsor: Prospective Bladder Cancer Infrastructure Foundation
Summary
Prospective nation-wide cohort of high-risk non-muscle-invasive, muscle-invasive and metastatic bladder cancer in the Netherlands
Official title: Prospective Bladder Cancer Infrastructure: an Infrastructure for Observational and Interventional Bladder Cancer Research (ProBCI)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
3600
Start Date
2020-10-04
Completion Date
2041-12-31
Last Updated
2025-08-11
Healthy Volunteers
Not specified
Conditions
Locations (23)
Jeroen Bosch Hospital
's-Hertogenbosch, Netherlands
ZGT
Almelo, Netherlands
Meander Medical Center
Amersfoort, Netherlands
Amsterdam UMC, location VUMC
Amsterdam, Netherlands
Rijnstate
Arnhem, Netherlands
Amphia Ziekenhuis
Breda, Netherlands
Albert Schweitzer Hospital
Dordrecht, Netherlands
Ziekenhuis Gelderse Vallei
Ede, Netherlands
Treant Hospital
Emmen, Netherlands
University Medical Center Groningen
Groningen, Netherlands
Spaarne Gasthuis
Hoofddorp, Netherlands
Medisch Centrum Leeuwarden
Leeuwarden, Netherlands
Alrijne Ziekenhuis
Leiderdorp, Netherlands
Maastricht University Medical Center
Maastricht, Netherlands
Canisius Wilhelmina Ziekenhuis
Nijmegen, Netherlands
Radboud univerisity Medical Center
Nijmegen, Netherlands
Erasmus Medical Center
Rotterdam, Netherlands
Zuyderland
Sittard, Netherlands
Elisabeth-TweeSteden Ziekenhuis
Tilburg, Netherlands
University Medical Center Utrecht
Utrecht, Netherlands
VieCuri
Venlo, Netherlands
SKB Winterswijk
Winterswijk, Netherlands
Isala
Zwolle, Netherlands